The impact of policy interventions to promote the uptake of biosimilar medicines in Belgium: a nationwide interrupted time series analysis

被引:0
作者
Yannick Vandenplas
Steven Simoens
Philippe Van Wilder
Arnold G. Vulto
Isabelle Huys
机构
[1] KU Leuven,Department of Pharmaceutical and Pharmacological Sciences
[2] Université Libre de Bruxelles (ULB),Ecole de Santé Publique
[3] Erasmus University Medical Center,Hospital Pharmacy
来源
Health Research Policy and Systems | / 21卷
关键词
Belgium; Biosimilar; Biological; Policy; Interrupted time series; ARIMA;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 142 条
  • [51] de Mora F(undefined)undefined undefined undefined undefined-undefined
  • [52] Remuzat C(undefined)undefined undefined undefined undefined-undefined
  • [53] Kapusniak A(undefined)undefined undefined undefined undefined-undefined
  • [54] Caban A(undefined)undefined undefined undefined undefined-undefined
  • [55] Ionescu D(undefined)undefined undefined undefined undefined-undefined
  • [56] Radiere G(undefined)undefined undefined undefined undefined-undefined
  • [57] Mendoza C(undefined)undefined undefined undefined undefined-undefined
  • [58] Moorkens E(undefined)undefined undefined undefined undefined-undefined
  • [59] Vandenplas Y(undefined)undefined undefined undefined undefined-undefined
  • [60] Barcina T(undefined)undefined undefined undefined undefined-undefined